P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RESULTS FROM THE AGILE STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE

• Hartmut Döhner,
• Pau Montesinos,
• Susana Vives Polo,
• Ewa Zarzycka,
• Jianxiang Wang,
• Marta Riva,
• Michael Heuser,
• Rodrigo Calado,
• Andre Schuh,
• Su-Peng Yeh,
• Jianan Hui,
• Diego Gianolio,
• Prapti A Patel,
• Christian Recher,
• Stephane de Botton

Affiliations

Hartmut Döhner

1 Ulm University Hospital, Department of Internal Medicine III, Ulm, Germany

Pau Montesinos

2 Hospital Universitari i Politècnic La Fe, Servicio de Hematología y Hemoterapia, València, Spain

Susana Vives Polo

3 Josep Carreras Research Institute,, Hospital Universitario Germans Trias i Pujol-ICO Badalona, Badalona, Spain

Ewa Zarzycka

4 Medical University of Gdansk, Department of Hematology and Transplantology, Gdańsk, Poland

Jianxiang Wang

5 Peking Union Medical College, Institute of Hematology & Hospital of Blood Disease, Tianjin, China

Marta Riva

6 ASST Grande Ospedale Metropolitano Niguarda, Department of Hematology, Oncology and Molecular Medicine, Milan, Italy

Michael Heuser

7 Hannover Medical School, Hannover, Germany

Rodrigo Calado

8 University of São Paulo, Ribeirão Preto School of Medicine, São Paulo, Brazil

Andre Schuh

9 Princess Margaret Cancer Centre, Toronto, Canada

Su-Peng Yeh

10 China Medical University, Taichung, Taiwan

Jianan Hui

11 Servier Pharmaceuticals, Boston, United States

Diego Gianolio

11 Servier Pharmaceuticals, Boston, United States

Prapti A Patel

11 Servier Pharmaceuticals, Boston, United States

Christian Recher

12 Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France

Stephane de Botton

13 Institut Gustave Roussy, Villejuif, France